Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer

Peer Review reports

Original Submission
23 Apr 2010	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
27 Nov 2010	Reviewed	Reviewer Report - Volkmar Muller
14 Mar 2011	Author responded	Author comments - Mark Aloysius
Resubmission - Version 3
14 Mar 2011	Submitted	Manuscript version 3
Publishing
18 May 2011	Editorially accepted
18 May 2011	Article published	10.1186/1471-2407-11-179

Back to article page